DOI QR코드

DOI QR Code

Isolation of Isoflavones and Soyasaponins from the Germ of Soybean

콩 배아로 부터 Isoflavone과 Soyasaponin의 동시 분리

  • 김선림 (농촌진흥청 국립식량과학원) ;
  • 이재은 (농촌진흥청 국립식량과학원) ;
  • 김율호 (농촌진흥청 국립식량과학원) ;
  • 정건호 (농촌진흥청 국립식량과학원) ;
  • 김대욱 (농촌진흥청 국립식량과학원) ;
  • 이춘기 (농촌진흥청 국립식량과학원) ;
  • 김미정 (농촌진흥청 국립식량과학원) ;
  • 김정태 (농촌진흥청 국립식량과학원) ;
  • 이유영 (농촌진흥청 국립식량과학원) ;
  • 황태영 (농촌진흥청 국립식량과학원) ;
  • 이광식 (농촌진흥청 국립식량과학원) ;
  • 김욱한 (농촌진흥청 국립식량과학원) ;
  • 권영업 (농촌진흥청 국립식량과학원) ;
  • 김홍식 (충북대학교 농업생명환경대학 식물자원학과) ;
  • 정일민 (건국대학교 생명환경과학대학 응용생물과학과)
  • Received : 2013.01.17
  • Accepted : 2013.04.04
  • Published : 2013.06.30

Abstract

The objective of present study was to simultaneously isolate of isoflavone and soyasaponin compounds from the germ of soybean seeds. Soy germ flours were defatted with hexane for 48h at room temperature, and methanolic extracts were prepared using reflux apparatus at $90^{\circ}C$ for 6h, two times. After extraction, extracts were separated with preparative RP-$C_{18}$ packing column ($125{\AA}$, $55-105{\mu}m$, $40{\times}150mm$), and collected 52 fractions were identified with TLC plate (Kieselgel 60 F-254) and HPLC, respectively. Among the identified isoflavone and soyasaponin fractions, isoflavone fractions were re-separated using a recycling HPLC with gel permeation column (Jaigel-W252, $20{\times}500mm$). Final fractions were air-dried, and the purified compounds of two isoflavones (ISF-1-1, ISF-1-2) and four soyasaponins (SAP-1, SAP-2, SAP-3, SAP-4) were obtained. Two isoflavone compounds (ISF-1-1, ISF-1-2) were acid-hydrolyzed for the identification of their aglycones, and confirmed by comparing with 12 types of isoflavone isomers. While the four kinds of soyasaponins were identified by using a micro Q-TOF mass spectrometer in the ESI positive mode with capillary voltage of 4.5kV, and dry temperature of $200^{\circ}C$. Base on the obtained results, it was conclude that ISF-1-1 is the mixture isomers of daidzin (43.4%), glycitin (47.0%), and genistin (9.6%), but ISF-1-2 is the single compound of genistin (99.8% <). On the other hand, soyasaponin SAP-1 is the mixture compounds of soyasaponin A-group (Aa, Ab, Ac, Ae, Af); SAP-2 is soyasaponin B-group (Ba, Bb, Bc) and E-group (Bd, Be); SAP-3 is soyasaponin B-group (Ba, Bb, Bc), E-group (Bd, Be), and DDMP-group (${\beta}g$); SAP-4 is soyasaponin B-group (Ba, Bb, Bc), E-group (Bd, Be), and DDMP-group (${\beta}g$, ${\beta}a$), respectively.

콩 관련 제품을 생산하는 과정에서 발생되는 부산물은 가축의 사료 및 퇴비 등에 이용되고 있으나 일부는 폐기물로 처리되어 추가 비용 및 각종 환경오염을 유발하는 등 사회적인 문제점으로 지적되고 있다. 따라서 본 연구에서는 가공 부산물로 다량 발생되는 콩 배아를 활용하여 생리활성물질인 isoflavone과 soyasaponin을 동시에 분리하는 방법을 개발하고자 실시하였다. 1. 콩 배아 methanol 추출물을 preparative $C_{18}$ column에 주입하고, 210 nm의 파장에서 0.5% 초산 용액 30%로부터 100% acetonitrile까지 분당 15mL의 유속으로 53분간 흘려주어 isoflavone과 soyasaponin 분획을 동시에 분리하였다. 2. Preparative $C_{18}$ column으로 분리된 isoflavone 및 soyasaponin 분획은 동결건조시켜 isoflavone 분말 ISF-1과 soyasaponin SAP-1, SAP-2, SAP-3 및 SAP-4의 분말을 얻었다. 3. Isoflavone 분획 ISF-1의 재분리는 젤투과 컬럼에서 100% acetonitrile을 분당 5 mL가 되도록 흘려주면서 254nm 파장에서 관찰하여 2종의 분획 ISF-1-1 및 ISF-1-2을 분리하였다. 4. 분리된 2종의 isoflavone 중 ISF-1-1은 그 조성이 daidzin, glycitin 및 genistin 이고, ISF-1-2는 genistin 단일물질이 주성분인 것으로 나타났다. 5. 분리된 4종의 soyasaponin 중 SP-1은 soyasaponin A계열인 Aa(MW: 1364), Ab(MW: 1436), Ac(MW: 1420), Ae(MW: 1202), Af(MW: 1274), SAP-2는 B계열인 Ba(MW: 958), Bb(MW: 942), Bc(MW: 912)와 E계열인 Bd(MW: 956), Be(MW: 940), SAP-3는 B계열인 Ba, Bb, Bc, E계열인 Bd, Be와 DDMP계열인 ${\beta}g$(MW: 1068), SAP-4는 B계열인 Ba, Bb, Bc, E계열인 Bd, Be와 DDMP계열인 ${\beta}g$, ${\beta}a$(MW: 1038)가 주성분임을 알 수 있었다.

Keywords

References

  1. Anderson, R. L. and W. J. Wolf. 1995. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 125: 581S-588S.
  2. Ariyo, A. A. and A. C. Villablanca. 2002. Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause? Postgrad Med. 111(1):23-30.
  3. Barnes, S. 1998. Evolution of the health benefits of soy isoflavones. Proc. Soc. Exp. Biol. Med. 271(3):386-392.
  4. Berhow, M. A. E. D. Wagner, S. F. Vaughn, and M. J. Plewa. 2000. Characterization and antimutagenic activity of soybean saponins. Mutation Research. 448:11-22. https://doi.org/10.1016/S0027-5107(99)00225-0
  5. Berhow, M. A., S. B. Kong, K. E. Vermillion, and S. M. Duval. 2006. Complete quantification of group A and group B soyasaponins in soybeans. J. Agric. Food Chem. 54:2035-2044. https://doi.org/10.1021/jf053072o
  6. Choi, Y. B. and H. S. Sohn. 1997. Recovery of isoflavones from soybean cooking water produced during soymilk manufacturing process. Korean J. Food Sci. Technol., 29: 522-526.
  7. Clarkson, T. B. 2002. Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 132:566S-569S.
  8. Decroos, K., J. P. Vincken, L. Heng, R. Bakker, H. Gruppen, and W. Verstraete. 2005. Simultaneous quantification of differently glycosylated, acetylated, and 2,3-dihydro-2, 5-dihydroxy-6-methyl-4H-pyran-4-one-conjugated soyasaponins using reversed-phase high-performance liquid chromatography with evaporative light scattering detection. J. Chromatogr. A. 1072:185-193. https://doi.org/10.1016/j.chroma.2005.03.021
  9. Diane F. B., H. Suzanne, and W. Wang. 2001. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & Therapeutics. 90:157-177. https://doi.org/10.1016/S0163-7258(01)00137-1
  10. Hayashi, K, H. Hayashi, N. Hiraoka, and Y. Ikeshiro. 1997. Inhibitory activity of soyasaponin II on virus replication in vitro. Planta Medica, 63, 102-105. https://doi.org/10.1055/s-2006-957622
  11. Hu, J.; S. O. Lee, S. Hendrich, and P. A. Murphy. 2002. Quantification of the group B soyasaponins by highperformance liquid chromatography. J. Agric. Food Chem. 50:2587-2594. https://doi.org/10.1021/jf0114740
  12. Iwamura J. and Kashiwara. 1984. Process for isolating saponins and flavonoids from leguminous plants. United State Patent. 4,428,876 (Jan. 31).
  13. Kinjo, J., M. Imagire, M. Udayama, T. Arao, and T. Nohara. 1988. Structure-hepatoprotective relationships study of soyasaponins I-IV having soyasapogenol B as aglycone. Planta Med. 64:233-236.
  14. Kitagawa I., H. K. Wang, T. Taniyama, and M. Yoshikawa. 1988a. Saponin and sapogenol. XLI. Reinvestigation of the structures of soyasapogenols A, B, and E, oleanenesapogenols from soybean. Structures of soyasaponins I, II, and III. Chem. Pharm. Bull. 36: 153-161. https://doi.org/10.1248/cpb.36.153
  15. Kitagawa I., T. Taniyama, Y. Nagahama, K. Okubo, F. Yamauchi, and M. Yoshikawa. 1988b. Saponin and sapogenol. XLII. Structures of acetyl-soyasaponins A1, A2, and A3, astringent partially acetylated bisdesmosides of soyasapogenol A, from American soybean, the seeds of Glycine max Merrill. Chem. Pharm. Bull. 36:2819-2828. https://doi.org/10.1248/cpb.36.2819
  16. Konoshima, T., M. Kokumai, M. Kozuka, H. Tokuda, H. Nishino, and A. Iwashima. 1992. Anti-tumor-promoting activities of afromosin and soyasaponin I isolated from Wistaria brachybotrys. J Nat Prod 55:1776-1778. https://doi.org/10.1021/np50090a011
  17. Koratkar, R. and A. V. Rao. 1997. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer. 27:206-209. https://doi.org/10.1080/01635589709514526
  18. Kudou, S., M. Tonomura, C. Tsukamoto, M. Shimoyamada, T. Uchida, and K. Okubo. Isolation and structural elucidation of the major genuine soybean saponin. Biosci. Biotechnol. Biochem. 1992, 56:142-143. https://doi.org/10.1271/bbb.56.142
  19. Lichtenstein, A. H. 2001. Got Soy ? (Editorial). Am. J. Clin. Nutr. 73(4):667-668.
  20. Liu, K. S. 1997. Soybeans: Chemistry, tchnology and uilization, Springer. p. 4-5.
  21. Shibuya M., K. Nishimura, N. Yasuyama, and Y. Ebizuka. 2010. Identification and characterization of glycosyltransferases involved in the biosynthesis of soyasaponin I in Glycine max. FEBS Letters. 584:2258-2264. https://doi.org/10.1016/j.febslet.2010.03.037
  22. Messina M. J., V. Persky, K. D. Setchell, and S. Barnes. 1994. Soya intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 21:113-131. https://doi.org/10.1080/01635589409514310
  23. Miksicek, R. J. 1994. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49(2-3): 153-160. https://doi.org/10.1016/0960-0760(94)90005-1
  24. Miyao, H., T. Arao, M. Udayama, J. Kinjo, and T. Nohara. 1998. Kaikasaponin III and soyasaponin I, major triterpenesaponins of Abruscantoniensis, act on GOT and GPT; influence on transaminase elevation of rat liver cells concomitantly exposed to CCl4 for one hour. Planta Med. 64:5-7. https://doi.org/10.1055/s-2006-957355
  25. Rao, A. V. and M. K. Sung. 1995. Saponins as anticarcinogens. J. Nutr. 125:717S-724S.
  26. Sanders, T. A. B., S. D. Tracey, G. David, J. M. George, and W. Helen. 2002. Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor ${\beta}1$ concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am. J. Clin. Nutr. 76(2):373-377.
  27. Sarkar, F. H. and Y. Li. 2003. Soy isoflavones and cancer prevention. Cancer Invest. 21:817-818. https://doi.org/10.1081/CNV-120023782
  28. Scheiber M. D., J. H. Liu, M. T. Subbiah, R. W. Rebar, and K. D. Setchell. 2001. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause. 8(5):384-392. https://doi.org/10.1097/00042192-200109000-00015
  29. Setchell K. D., N. M. Brown, and E. Lydeking-Olsen. 2002. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132(12):3577-3584.
  30. Setchell, K. D. and A. Cassidy. 1999. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129:758S-767S.
  31. Shiraiwa, M., S. Kudou, M. Shimoyamada, K. Harada, and K. Okubo, 1991. Composition and structure of "group A saponin" in soybean seed. Agric. Biol. Chem. 55:315-322 & 55:911-917. https://doi.org/10.1271/bbb1961.55.315
  32. Sirtor, C. R. 2001. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf. 24(9):665-682. https://doi.org/10.2165/00002018-200124090-00003
  33. Taniyama T., Y. Nagahama, M. Yoshikawa, and I. Kitagawa. 1988. Saponin and sapogenol. XLIII. acetyl-soyasaponins A4, A5, and A6, new astringent bisdesmosides of soyasapogenol A, from Japanese soybean, the seeds of Glycine max Merrill. Chem. Pharm. Bull. 36:2829-2839. https://doi.org/10.1248/cpb.36.2829
  34. Tham, D. M., C. D. Gardner, and W. L. Haskell. 1998. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83(7):2223-2235. https://doi.org/10.1210/jc.83.7.2223
  35. Tikkanen, M. J. and H. Adlercreutz. 2000. Dietary soyderived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem. Pharmacol. 60(1):1-5. https://doi.org/10.1016/S0006-2952(99)00409-8
  36. Tsukamoto, C., A. Kikuchi, K. Harada, K. Kitamura, and K. Okubo. 1993. Genetic and chemical polymorphisms of saponins in soybean seed. Phytochemistry. 34(5):1351-1356. https://doi.org/10.1016/0031-9422(91)80028-Y
  37. Vlietinck, A. J., T. De Bruyne, S. Apers, and L. A. Pieters. 1998. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 64:97-109. https://doi.org/10.1055/s-2006-957384
  38. Wang, H., and P. Murphy. 1994. Isoflavone composition of American and Japanese soybeans in Iowa: Eff ects of variety, crop year and location. J. Agric. Food Chem. 42: 1674-1677. https://doi.org/10.1021/jf00044a017
  39. Yoshiki Y., S. Takagi, M. Watanabe, and K. Okubo, 2005. Fractionation of soybean functional glycosides from soywaste based on the chemical reaction of soyasaponin $\beta$g. Food Chemistry. 93:591-597. https://doi.org/10.1016/j.foodchem.2004.10.042
  40. Yoshiki, Y. M. Kinumi, T. Kahara, and K. Okubo. 1996. Chemiluminescence of soybean saponins in the presence of active oxygen species. Plant Science. 116:125-129. https://doi.org/10.1016/0168-9452(96)04375-0
  41. Yoshikoshi, M., Y. Yoshiki, K. Okubo, J. Seto, and Y. Sasaki. 1996. Prevention of hydrogen peroxide damage by soybean saponins to mouse fibroblasts. Planta Med. 62: 252-255. https://doi.org/10.1055/s-2006-957871

Cited by

  1. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein KinaseαPathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease vol.19, pp.6, 2016, https://doi.org/10.1089/jmf.2015.3604